Literature DB >> 35505814

A Practical Approach to the Diagnosis and Treatment of Abdominal Bloating and Distension.

David J Cangemi1, Brian E Lacy1.   

Abstract

Abdominal bloating and distension are highly prevalent symptoms that can negatively impact quality of life and lead to medical consultation. Despite their prevalence, symptoms of bloating and distension pose a unique diagnostic and therapeutic challenge, as they are inherently nonspecific symptoms with a complex etiology, and no uniform diagnostic or treatment algorithm currently exists. Additionally, bloating is common among disorders of gut-brain interaction, which can be difficult to treat. This article offers a practical approach for evaluating and treating symptoms of bloating and distension through discussion of 5 common etiologies: diet, small intestinal bacterial over-growth, constipation, visceral hypersensitivity, and abdomino-phrenic dyssynergia. An effective personalized evaluation and treatment plan can be established to address symptoms of bloating and distension through consideration of these etiologies in the context of the patient's individual characteristics and presentation.
Copyright © 2022, Gastro-Hep Communications, Inc.

Entities:  

Keywords:  Bloating; abdomino-phrenic dyssynergia; constipation; distension; pelvic floor dysfunction; small intestinal bacterial overgrowth; visceral hypersensitivity

Year:  2022        PMID: 35505814      PMCID: PMC9053509     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  63 in total

1.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

2.  Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid.

Authors:  D Storey; A Lee; F Bornet; F Brouns
Journal:  Eur J Clin Nutr       Date:  2006-09-20       Impact factor: 4.016

3.  Bloating is associated with worse quality of life, treatment satisfaction, and treatment responsiveness among patients with constipation-predominant irritable bowel syndrome and functional constipation.

Authors:  L Neri; P Iovino
Journal:  Neurogastroenterol Motil       Date:  2016-02-12       Impact factor: 3.598

4.  A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome.

Authors:  J Tack; D Broekaert; B Fischler; L Van Oudenhove; A M Gevers; J Janssens
Journal:  Gut       Date:  2006-01-09       Impact factor: 23.059

5.  In functional dyspepsia, hypersensitivity to postprandial distention correlates with meal-related symptom severity.

Authors:  Ricard Farré; Hanne Vanheel; Tim Vanuytsel; Tatsuhiro Masaoka; Hans Törnblom; Magnus Simrén; Lukas Van Oudenhove; Jan F Tack
Journal:  Gastroenterology       Date:  2013-05-20       Impact factor: 22.682

6.  Bloating and distention in irritable bowel syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency.

Authors:  Yujin Zhu; Xia Zheng; Yanqun Cong; Hua Chu; Michael Fried; Ning Dai; Mark Fox
Journal:  Am J Gastroenterol       Date:  2013-08-06       Impact factor: 10.864

Review 7.  Expert consensus document: Advances in the evaluation of anorectal function.

Authors:  Emma V Carrington; S Mark Scott; Adil Bharucha; François Mion; Jose M Remes-Troche; Allison Malcolm; Henriette Heinrich; Mark Fox; Satish S Rao
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-04-11       Impact factor: 46.802

8.  Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome--results of two randomized, placebo-controlled studies.

Authors:  D A Drossman; W D Chey; J F Johanson; R Fass; C Scott; R Panas; R Ueno
Journal:  Aliment Pharmacol Ther       Date:  2008-11-04       Impact factor: 8.171

9.  Diagnosing Small Intestinal Bacterial Overgrowth: A Comparison of Lactulose Breath Tests to Small Bowel Aspirates.

Authors:  David J Cangemi; Brian E Lacy; Journey Wise
Journal:  Dig Dis Sci       Date:  2020-07-17       Impact factor: 3.199

10.  Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation.

Authors:  Anthony J Lembo; John F Johanson; Henry P Parkman; Satish S Rao; Philip B Miner; Ryuji Ueno
Journal:  Dig Dis Sci       Date:  2011-07-19       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.